SLC5A5 and thyroid gland carcinoma: Figure 1 summarizes the transcriptional and translational pathways involved in regulation of NIS expression. By deconvoluting the mechanisms involved in NIS downregulation or loss of function in thyroid cancer, it is possible to identify targets that could potentially overcome RAI refractoriness in thyroid cancers [17,20].